Hester Biosciences reports 35% growth in 2012-13
The company on Thursday said its turnover increased to Rs 651.04 mn over 482.64 mn recorded in 2011-12.

The board of directors have recommended a dividend of Rs 2 per equity share for 2012-13.The company got awarded WHO-GMP certification in 2012-13.It developed Bivalent Marek's Disease Live Vaccine for the poultry and 5 cattle vaccines.
Download ET Markets APP